Because a biotech patent granted by the European Patent Office late last year omitted a key phrase, a patent for what appears to be an impermissible technology issued to Scotland’s University of Edinburgh.
The claim for Patent 0695351 covers “a method of preparing a transgenic animal” but did not include the term “nonhuman.” As a result, the patent appears to grant the rights to genetic manipulation of humans, which is barred under European Union guidelines.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
